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The following is a transcript of a live presentation at
the 2019 Charleston Conference. Video of this session
is available at https://youtu.be/xxMpezF2sCo.
Meg White: I’m up here on the stage and we said
we were ready to go and the mics came live and the
music went down, so, good afternoon and welcome.
My name is Meg White and I’m here this afternoon
to kick off our plenary session.
A few housekeeping items: first, please silence all
your cell phones and electronic devices. Just for your
information, and Big Brother’s still listening, probably, the session is being recorded this afternoon.
We’re going to endeavor to leave time for questions.
Please use the microphones that are in the audience
and please be sure to state your name and your
affiliation when you ask a question. All right, well,
I’m very pleased to be joined on the stage today by
Dr. Patty Brennan. She is director of the National
Library of Medicine. Dr. Brennan’s career and her
background are extensive. She has a unique combination of engineering, information technology, and
clinical care. Since being named director of the NLM
in August 2016, Dr. Brennan has led the development
of a strategic plan for the National Library of Medicine and will speak to us today about the future of
biomedical communication. Dr. Patty Brennan.
Patricia Flatley Brennan: Good afternoon. You must
be wondering what’s a medical library doing in this
meeting today? Well, how many of you have had
a health problem in the last 10 years? Okay. You
need us. I will say not much more just yet, but I will
tell you that the National Library of Medicine is the
world’s largest biomedical library. We are a part of
the National Institutes of Health. We have 1,700
women and men that work together every day to
bring you PubMed, MEDLINEplus, clinicaltrials.gov,
and to conduct research and data science and in the
application of biomedical informatics technologies
to clinical data. I’m extremely proud to be a part
of a federal library and I’m very delighted to be
addressing this audience because I see intersections
between the concerns of publishers, librarians, and
federal libraries. We are not a lending library. We are
a repository library. We do participate in interlibrary
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loan. We do have library cards still, by the way. You
can get a library card to the National Library of Medicine, but mostly we serve as a resource to the world.
We provide the largest bibliographic repository,
PubMed; many of you, I suspect, have run into that
at one time or another. There are overall 30 million
bibliographic citations in PubMed. We’re adding
1 million a year. We also, though, as you look on the
screen above you, have a number of other products that are important to the world. Our genomic
repositories, our clinical variance, our dbGaP, these
are data repositories that have billions of genomic
sequences in them and I’m going to tell you some
exciting news about those as we go forward.
But we also provide information to communities.
TOXNET provides important information about
the environmental quality in a community. At
clinicaltrials.gov a registry of clinical trials where
patients who are worried and wondering can they
find a treatment for complex illness can go there.
DOCLINE is a way that we use to deliver biomedical
knowledge to anyone who may need it anywhere in
the world. WISER up in the right‐hand corner is an
in‐the‐moment smartphone‐held application that
gives specific toxic management information to first
responders.
We touch many lives, many places everywhere in the
world, but we know that biomedical communications
is changing and it is no longer your mother’s library.
It can no longer be your mother’s library because we
must keep pace with communication and serve the
public. So, I’d like you to take a minute and watch
a brief film that gives you our vision of where we
think biomedical communications is going. (Video:
Anticipating the Future of Biomedical Communication plays.)
I’m very proud to be the director of an engine that
powers data‐driven discovery and data‐powered
health. We have just launched our strategic plan. Our
10‐year vision of what we will be doing is grounded
in three key pillars: first, to accelerate discovery
and advance health through data‐driven research.
Second, reach more people in more ways through
enhanced dissemination and engagement; and third,
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to prepare a workforce, including a citizen workforce,
for data‐driven research and health. We envision a
future where a library becomes not just a building or
a website but an ecosphere, as you see on the right‐
hand side, of interconnected digital research objects
where literature, protocols, study data, funding
opportunities, pipeline and pathways for genomic
and assessments all are interconnected in the library
sweet spot, as many of you know, is in structuring
underneath each of those ovals and in building the
interconnections between them.
I’m going to talk with you for the next 20 minutes or
so about what the National Library of Medicine is
doing to support biomedical communications in the
21st century and I’m going to explain, address three
key aspects. First of all, improving the usability and
access to the research literature. Our sweet spot,
our strong point in the National Library of Medicine
as a part of the NIH is to bring research knowledge
together for the world. Second, to promote open
science and data sharing; and third, to guide 21st‐
century scientific communication. Now, the National
Library of Medicine is almost 300 years old and we’re
preparing for this through many conversations around
the world. What we began and we will continue to
be is fundamentally a collection, but our collection is
changing, and I heard some marvelous models this
morning about the new collection. We have been
custodians. People think of a library as a place that
holds things and certainly preservation for the future
for future access is a critical role of the library, but
increasingly we connect to our connections and in the
future we have to focus on discovery on the fly and, as
I heard this morning, building new collections based
on the patterns of those discoveries. The National
Library of Medicine is primarily bringing literature and
knowledge and data into the hands of those who need
this, but we need to improve the usability and access
to the research literature.
This is our interface to PubMed. I suspect many
of you have looked at PubMed for your patrons,
for yourselves, maybe for someone in your family.
PubMed is an amazing resource: 30+ million articles,
two and a half million daily users, two and a half
million users every day, most of them not coming
to our building, by the way, coming to us electronically. About 3 million searches and 9 million page
views, but what we know is that 80% of the searches
that are done on PubMed have more than one
page of search results done and 90% of the people
who search PubMed never go to the second page.
So, if the article that you need or the article that
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you’ve published is on page 2, you’re dead. We are
now committed to improving search and improving retrieval by artificial intelligence and machine
learning approaches. We want to first and foremost
improve the search quality, make sure we bring the
most highly relevant resources in an efficient manner to our users. But, second, we need to improve
usability. So, what we are doing is adopting, out of
the research from some of our intramural researchers, what we refer to as a learning to rank algorithm.
Let me walk you through the diagram on the screen
for just a moment. On the left‐hand side you see our
30 million citations, always in partnership with the
publishers in an XML format, that are tagged with
keywords, maybe, and then have human indexing
applying the MeSH terminology to make the metadata useful for search, but we also are now tagging it
with experience information, how often was this particular citation pulled up, for example, or what other
citations were pulled up with this one. An individual
launches a query at step one. That query is exploded
through our PubMed interface and a set of series
of what we call hits/matches are drawn up, mostly
running about in the area of between 500 and 2,000
site hits for each one. We need to sort them better.
Currently we present them in reverse chronological
order. That’s not enough. We also, from that zone,
then in step three apply our new AI algorithm to
the first 500 certain hit search returns. The first 500
results are then resorted to create a best match of
what the user has learned, is looking for, and then
from that we monitor experience data, how often
are those units searched on, how often are they
clicked through, to make sure we’re actually improving our algorithm and have ways to lead experience
into improvement.
So, here’s what is returned to an individual now. If
you look at this screen, this is a standard PubMed
search screen. On the right‐hand side you see a
green box that has best match or most recent. We
currently return most recent searches, but we are
getting the community ready for the fact that we
have this best match algorithm available so the red
box that you see in the center alerts the user to
some other articles that they may not find on the
first page. Here’s our best match. Here’s what we
think might be useful to you. Beginning in about
90 days our default search will be the best match
search, although you will be able to always get
reverse chronological order searches returned.
Here’s what our new interface is going to look like.
There’s three things I want to call your attention to

here. First, again, look in the upper right‐hand corner. You may toggle between best match and reverse
chronological order but, second, each of our citations
now has a small series of phrases underneath it. We
call these “snippets” that show the match to your
search phrase so that you don’t have to click through
to read an abstract to determine whether or not
you want a particular article. On the left‐hand side
you see a histogram. There’s a slider bar underneath
that histogram. It’s a reflection of how many articles
per year were published in that according to that
topic that you requested. You’re able to constrain
your search to certain periods of time, thus allowing
the user to have a better experience with PubMed.
We’re excited about this. You can see this today,
actually, if you Google PubMed Labs but we believe
we’ll be going live in about 90 days for this. We are
still open to your input.
Now, the world is moving toward data and the world
is moving toward openness. That is not a surprise
to the audience here. I want to talk to you a little
bit about what the National Library of Medicine is
doing to improve and promote open science and
data sharing. First and foremost, in our PubMed
Central literature repository we hold the full text of
over 5 million articles, most of them from federally
funded research or historically valuable articles.
These are freely available. About half of them are
available for machine processing and the other half
are available downloadable for human reading.
Within this PubMed Central repository now, though,
we are able to link data sets directly to articles so the
data in support of an article can be made available to
an individual. We have two key repositories: our citation repository, PubMed, and our full‐text literature
repository, PubMed Central. Each of these provides
a pathway to data. Within PubMed, our citation
repository, we make link outs to Figshare, we make
link outs to various public data repositories as you
see on the left side. Within PubMed Central we have
data citations and other supplementary material
connected directly to the article. We know this is
not the final solution, but it’s now a pathway to get
direct access to data. It’s been a bit of an experiment
to get our researchers to curate their own data. I will
tell you they need a little help with this. Libraries
have lots of work to do in the future. Almost all of
what I’ve described to you so far is housed at the
National Library of Medicine and can be downloaded
by an individual through our FTP sites or through
industries that we also have partnerships with, but
our genomic databases are growing so rapidly that
the download is becoming impossible to support,

so we have recently started to move some of our
high‐valued genomic data sets into cloud instances,
into commercial cloud storage within Amazon, AWS,
and Google Cloud. We have—the first repository
we launched was the Sequence Read Archive. The
Sequence Read Archive is about a 12 PB repository of
annotated sequences, genomic sequences that are
now available that can be interrogated and operated
on in cloud instances. We are also in the process
of modifying our search and analysis algorithms
including the blast algorithm, which is a sequence
alignment algorithm to make these possible to run
in cloud instances. Those of you who have started
to migrate into cloud instances know it’s not merely
a matter of lift and shift. You have to restructure
things, you have to find new pathways in. Fundamentally, we are committed to making data accessible, and clinical data are accessible through the fast
interoperability—fast health care interoperability
resource. This is one step we are taking toward the
goal of making all data findable, accessible, inter‐
operable, and reusable.
Now, I’ve talked to you about literature; I’ve talked
to you about data. But what brings knowledge out of
data are the analytical tools, the models we apply to
data. The National Library of Medicine is questioning
how do we build a library of models? What characteristics? What is the grammar for models? What
are the metadata for artificial intelligence models
or machine‐learning algorithms? We are beginning
to explore how to code and document and make
accessible the analytical tools that one can use to
operate on our resources. We believe that models
must be described by key metadata or data elements
including the type, the purpose, the assumptions
built, when it was made, and also most importantly,
what was the intended use and can this model scale?
Building analytical models takes millions of dollars of
research investments and if they’re only useful for
solving one problem, we’ve wasted federal dollars, so we need to know how do we make models
scalable and when do we do that? That is a process
of model verification and validation, and the library
is becoming a partner with scientists and methodologists around the world to be able to make this
happen.
But we are deeply in a period of change and I’m
bringing the library along to improve the discoverability of the biomedical literature and through the
literature data and through the “data to models.”
I’m happy to be saying today we’re announcing the
launch of MEDLINE 2022. Those of you who have
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been involved in the library know we have been
quietly working on this for a while. MEDLINE 2022 is
an approach to make our literature more available
more quickly in a way that will accelerate scientific
discovery. We are focusing on three key areas: first,
curation at scale; second, expanding metadata;
and third, creating strategies that are efficient and
connected. Our activities for creation at scale are
all targeted toward that upper right‐hand corner.
Having a citation indexed within 24 hours of being
deposited. We cannot do this without partnership
with the publishers. We recognize that your ability
to send us XML and properly tagged articles allows
us to accelerate our indexing strategy. We must also
recognize that human curation, a very expensive
effort, a very important effort, has to be preserved
for those articles most in need of that. Second, to
develop expanded metadata. We are focusing on
optimizing metadata to support interconnectedness
across our various resources and registry. We are
focusing also on expanding the use of funders’ metadata in our literature services. We heard this morning how important the funders are in open access
and open data sharing. We need to make sure we
have a way to support the funders in looking at and
evaluating the impact of their resources. And finally,
our emphasis on creating things in an efficient and
connected way. We are enhancing the MeSH vocabulary. We’re working on adding authoritative vocabularies to MeSH to increase it, and MeSH, by the way,
I’m sorry, is a medical subject heading. I apologize for
talking federal jargon in front of you. This is the most
essential terminology that we use to do our indexing
and metadata.
The last advance I want to talk to you about today I
think might be the most commercial and I’m quite
interested in your reactions to this. The National
Library of Medicine, in cooperation with the National
Institutes of Health, wants to increase the discoverability and use of preprints as part of biomedical
scientific communication. We’re announcing the
beginning of a pilot for examining preprints and
making them accessible through our existing citation
repositories and literature databases. The National
Library of Medicine preprint pilot has as its goal
to improve the discoverability of preprints, which
downstream should accelerate discovery in science
and, frankly, make science more efficient so we’re
not replicating studies that are already done, which
is a waste of federal dollars. In order to make this
happen, certain conditions have to be made. The
preprint gets deposited into a preprint server. The
preprint is then shipped to the PubMed Central, our
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repository literature database, and an associated
bibliographic citation is made in PubMed. All of the
records of the preprints will be clearly marked as the
material has not been peer‐reviewed. It’s critical that
our readers understand this. Our experiment is limited to NIH‐funded research or preprints coming out
of NIH‐funded research. The preprints must be fully
available in an XML markup. That’s the responsibility
of the preprint service and the repository must have
a license that allows for the inclusion of that particular document into a noncommercial repository.
So, our plan is in partnership with existing preprint
services that we will make their materials more discoverable through our interface.
The experiment is designed to accelerate scientific
output of NIH funding. Clearly, that’s what we’re
interested in. The National Library of Medicine is part
of an enterprise that spends almost $40 billion a year
of tax money to bring health to society. We must be
good stewards of that. NIH recently has been encouraging, but not requiring, its investigators to use
preprints in the service of conveying their information and the results of their research early. We have
a public access policy that requires that all archival
articles supported by NIH be made freely available to
the public in short periods of time, but we want to
encourage investigators to start using preprint repositories that can accelerate access to the information
that they have available and fundamentally that
help us to support the guidance that NIH is giving
to our researchers of how to communicate. Now, in
this era of publication we know scientists have many
choices of where to put their articles. The National
Institutes of Health remains committed to expanding access to the scientific literature, but we want
to do that in a way that it maintains the integrity of
the scientific literature and yet, as a federal body,
we do not give direct advice of which journals are
acceptable to publish and which are not acceptable
to publish and we do not maintain a whitelist or a
blacklist, but rather the NIH has released guidance to
its community to say that our publication policy is to
look for journals, look for outlets that have rigorous
editorial policies, have clearly defined ethics, have
an emphasis on communicating in a scholarly way to
the public. The National Library of Medicine is committed to working with partnerships. As we develop
the preprint experiment it is absolutely essential that
we maintain a relationship with the preprint service.
We will not become a publisher. We will not become
a preprint service on our own. As you notice, the
preprint services that we are willing to partner with
have the same criteria of good publication criteria

that NIH has listed that we need to use—have appropriate licensing, there must be rigorous transparent
policies and practices to address plagiarism, competing interests, misconduct; and fundamentally
the preprint service itself must maintain accurate
records for the preprints and allow us to have a way
to coordinate, that is, to align archival publications
with various forms of preprint activity, including the
development of and increasing expanding use of
open peer review.
The National Library of Medicine is and will continue
to be a trusted source of health information. We
do not produce the information. We do not publish
the information but we facilitate the access to that
information. Participation in the National Library
of Medicine’s experiments with PubMed, our new
interface, our experiments with the preprint service,
and our use of our new and improved MEDLINE 2022

indexing strategies we hope will increase the accessibility of trustable health information to the public
at large. We recognize that in an era of machine
learning, machine engagement, artificial intelligence,
the concept of trust must move beyond a human
level of developing an interpersonal agreement of
what trusted information is to computable machine/
machine interfaces that remain trustable and private.
As a library, we are committed to the values of library
science, which indicate full, unfettered access to
health information in a way that is unsupervised without unnecessary oversight so that the examination
of ideas, the examination of science to create new
ideas becomes a tool that is useful for accelerating
science everywhere in the world. I thank you for the
opportunity to talk with you about how our focus on
improving biomedical science communications will
accelerate health for all and I’m ready to hear your
comments and questions. Thank you very much.
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